CytoMed Therapeutics
GDTC
#10693
Rank
โ‚น1.09 B
Marketcap
โ‚น92.69
Share price
-1.03%
Change (1 day)
-46.89%
Change (1 year)

Revenue for CytoMed Therapeutics (GDTC)

Revenue in 2025: โ‚น24.39 Million

According to CytoMed Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น24.39 Million. In 2025 the company made a revenue of โ‚น24.39 Million an increase over the revenue in the year 2024 that were of โ‚น4.93 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CytoMed Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025โ‚น24.39 M394.14%
2024โ‚น4.93 M
2023N/A
2022N/A
2021N/A
2020N/A